Dako to Collaborate with Merck on Development of Companion Diagnostics for Cancer Treatment

[at noodls] – GLOSTRUP, Denmark, Jan. 9, 2014 Dako, an Agilent Technologies company, announced today it has entered into a master framework agreement with Merck to develop companion diagnostic tests for oncology drugs … more

View todays social media effects on A

View the latest stocks trending across Twitter. Click to view dashboard